Report Summary
Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump.
In 2020, the global Rapid Acting Insulins market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Rapid Acting Insulins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid Acting Insulins development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Novo Nordisk
Sanofi
...
Market segment by Type, the product can be split into
Lispro
Aspart (NovoLog)
Glulisine (Apidra)
Market segment by Application, split into
Type 1 Diabetes
Type 2 Diabetes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Rapid Acting Insulins status, future forecast, growth opportunity, key market and key players.
To present the Rapid Acting Insulins development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Rapid Acting Insulins are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rapid Acting Insulins Market Size Growth Rate by Type (2017-2027)
1.4.2 Lispro
1.4.3 Aspart (NovoLog)
1.4.4 Glulisine (Apidra)
1.5 Market by Application
1.5.1 Global Rapid Acting Insulins Market Share by Application (2017-2027)
1.5.2 Type 1 Diabetes
1.5.3 Type 2 Diabetes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Rapid Acting Insulins Market Size
2.2 Rapid Acting Insulins Growth Trends by Regions
2.2.1 Rapid Acting Insulins Market Size by Regions (2017-2027)
2.2.2 Rapid Acting Insulins Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Rapid Acting Insulins Market Size by Manufacturers
3.1.1 Global Rapid Acting Insulins Revenue by Manufacturers (2017-2020)
3.1.2 Global Rapid Acting Insulins Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Rapid Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.2 Rapid Acting Insulins Key Players Head office and Area Served
3.3 Key Players Rapid Acting Insulins Product/Solution/Service
3.4 Date of Enter into Rapid Acting Insulins Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Rapid Acting Insulins Market Size by Type (2017-2020)
4.2 Global Rapid Acting Insulins Market Size by Application (2017-2020)
5 United States
5.1 United States Rapid Acting Insulins Market Size (2017-2020)
5.2 Rapid Acting Insulins Key Players in United States
5.3 United States Rapid Acting Insulins Market Size by Type
5.4 United States Rapid Acting Insulins Market Size by Application
6 Europe
6.1 Europe Rapid Acting Insulins Market Size (2017-2020)
6.2 Rapid Acting Insulins Key Players in Europe
6.3 Europe Rapid Acting Insulins Market Size by Type
6.4 Europe Rapid Acting Insulins Market Size by Application
7 China
7.1 China Rapid Acting Insulins Market Size (2017-2020)
7.2 Rapid Acting Insulins Key Players in China
7.3 China Rapid Acting Insulins Market Size by Type
7.4 China Rapid Acting Insulins Market Size by Application
8 Japan
8.1 Japan Rapid Acting Insulins Market Size (2017-2020)
8.2 Rapid Acting Insulins Key Players in Japan
8.3 Japan Rapid Acting Insulins Market Size by Type
8.4 Japan Rapid Acting Insulins Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Rapid Acting Insulins Market Size (2017-2020)
9.2 Rapid Acting Insulins Key Players in Southeast Asia
9.3 Southeast Asia Rapid Acting Insulins Market Size by Type
9.4 Southeast Asia Rapid Acting Insulins Market Size by Application
10 India
10.1 India Rapid Acting Insulins Market Size (2017-2020)
10.2 Rapid Acting Insulins Key Players in India
10.3 India Rapid Acting Insulins Market Size by Type
10.4 India Rapid Acting Insulins Market Size by Application
11 Central & South America
11.1 Central & South America Rapid Acting Insulins Market Size (2017-2020)
11.2 Rapid Acting Insulins Key Players in Central & South America
11.3 Central & South America Rapid Acting Insulins Market Size by Type
11.4 Central & South America Rapid Acting Insulins Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rapid Acting Insulins Introduction
12.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2020)
12.1.5 Eli Lilly Recent Development
12.2 Novo Nordisk
12.2.1 Novo Nordisk Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rapid Acting Insulins Introduction
12.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2020)
12.2.5 Novo Nordisk Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rapid Acting Insulins Introduction
12.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2017-2020)
12.3.5 Sanofi Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
